INCY
Incyte Corp
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Incyte has 4 disclosed suppliers and 1 disclosed customer in SEC filings.
SentenceFor example, we received capital in connection with the exclusive option agreement entered into with Incyte Corporation ("Incyte") in November 2025 in exchange for the option to acquire certain rights, titles and interests related to our mutative selective JAK2V617F inhibitor program.
SentenceAcquisition-related contingent consideration, which consists of our future royalty obligations to ARIAD/Takeda, was recorded on the acquisition date, June 1, 2016, at the estimated fair value of the obligation, in accordance with the acquisition method of accounting.
INCY 10-Kaccession 0000879169-26-000010
SentenceUnder the settlement agreement, we paid Novartis $280.0 million as the settlement of disputed royalties on net sales of JAKAFI in the United States through December 31, 2024, and agreed to reduce by 50% the royalty rate payable by us on future net sales of JAKAFI in the United States beginning January 1, 2025.
INCY 10-Kaccession 0000879169-26-000010
Last report3 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−0.06%
vs ±7.5% implied · ×0.01
shaded = implied · ▲▼ = realized
Incyte Corp
120.41
Linked news
Expected move
No implied move.